Therese M. Vaughan
Therese M. Vaughan's purchase track record
Therese M. Vaughan has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 5/19/2025 | HG | $100K | +8.3% | +20.8% | +11.9% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
HG posts strong results and retains overweight rating. Hamilton Insurance reported results that beat the recent market upswing, prompting analysts to note its outperformance versus other finance stocks this year. Wells Fargo kept an overweight stance on the company but lowered its price target to $40. A recent low‑volatility stock list flagged HG as a stock to avoid, highlighting concerns about its volatility profile. The stock currently trades near its 52‑week high with a trailing P/E of 6.0.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
West Bancorporation Featured in Dividend Stock Discussion. West Bancorporation was highlighted in a recent article discussing high-growth dividend stocks. The company offers a 4.07% dividend yield, which is a key factor in this context. Its current valuation shows a trailing P/E ratio of 13.0, with an average analyst target price of $29.00.
Transaction History
| VRSK | ▲ Buy | Grant | 1,347 | $0 | 5/19/2026 | View on chart |
| HG | ▲ Buy | Grant | 4,929 | $0 | 5/5/2026 | View on chart |
| WTBA | ▲ Buy | Grant | 1,430 | $0 | 4/23/2026 | View on chart |
| VRSK | ▲ Buy | Grant | 735 | $0 | 5/20/2025 | View on chart |
| HG | ▲ Buy | Open Market | 4,750 | $100K | 5/19/2025 | View on chart |
| HG | ▲ Buy | Grant | 7,187 | $0 | 5/15/2025 | View on chart |
| WTBA | ▲ Buy | Grant | 1,738 | $0 | 4/24/2025 | View on chart |
| HG | ▲ Buy | Grant | 8,955 | $0 | 6/13/2024 | View on chart |
| VRSK | ▲ Buy | Grant | 847 | $0 | 5/15/2024 | View on chart |
| WTBA | ▲ Buy | Grant | 1,945 | $0 | 4/26/2024 | View on chart |
| VRSK | ▼ Sell | Open Market | 6,500 | $1.5M | 8/21/2023 | View on chart |
| VRSK | ▲ Buy | Option Exercise | 4,256 | $359K | 8/8/2023 | View on chart |
| VRSK | ▲ Buy | Option Exercise | 4,716 | $344K | 8/8/2023 | View on chart |
| VRSK | ▲ Buy | Option Exercise | 5,686 | $346K | 8/8/2023 | View on chart |
| VRSK | ▲ Buy | Option Exercise | 4,671 | $378K | 8/8/2023 | View on chart |
| VRSK | ▼ Sell | Open Market | 6,129 | $1.4M | 8/8/2023 | View on chart |
| VRSK | ▲ Buy | Grant | 958 | $0 | 5/17/2023 | View on chart |
| WTBA | ▲ Buy | Grant | 1,868 | $0 | 4/27/2023 | View on chart |
| VRSK | ▼ Sell | Open Market | 932 | $179K | 9/9/2022 | View on chart |
| VRSK | ▲ Buy | Option Exercise | 2,889 | $175K | 9/9/2022 | View on chart |
| VRSK | ▲ Buy | Option Exercise | 2,023 | $123K | 8/9/2022 | View on chart |
| VRSK | ▼ Sell | Open Market | 629 | $125K | 8/9/2022 | View on chart |
| VRSK | ▲ Buy | Grant | 792 | $0 | 7/1/2022 | View on chart |
| WTBA | ▲ Buy | Grant | 1,167 | $0 | 4/28/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Verisk price targets trimmed as analysts weigh AI impact
BMO Capital and Morgan Stanley recently lowered their price targets for Verisk Analytics to $217 and $215, respectively, while maintaining positive ratings. This adjustment reflects ongoing debate among analysts regarding the company's growth outlook and the potential impact of artificial intelligence on its business model. The stock is currently trading near the upper end of its 52-week range, with an average analyst target of $227.94.
Verisk price targets trimmed as analysts weigh AI impact. BMO Capital and Morgan Stanley recently lowered their price targets for Verisk Analytics to $217 and $215, respectively, while maintaining positive ratings. This adjustment reflects ongoing debate among analysts regarding the company's growth outlook and the potential impact of artificial intelligence on its business model. The stock is currently trading near the upper end of its 52-week range, with an average analyst target of $227.94.